How a Pioneering Idea in Regenerative Medicine Became a Leading Allograft & Bio-Implant Company

Are you curious about how an innovative idea in regenerative medicine evolved into a leading company specializing in allografts and bio-implants? In our exclusive podcast, brought to you by Furbo, discover the inspiring journey, challenges, and successes of Regen Allograft (Faravardeh Baft Iranian). This company is committed to revolutionizing the medical landscape by leveraging cutting-edge knowledge and global standards.

The Beginning of a Vision

Founded in 2011 by a team of researchers and faculty members from Tehran University of Medical Sciences, Regen Allograft set out with a clear mission: to produce high-quality, affordable allograft products for patients in need. From day one, the company prioritized compliance with international standards, ensuring the safety and efficacy of its products.

Mission: Innovating Regenerative Medicine

Regen Allograft is dedicated to developing advanced medical solutions by integrating state-of-the-art technologies and collaborating with scientific institutions. The company focuses on addressing critical needs in regenerative medicine and biomedical engineering, particularly in orthopedics, dentistry, cardiovascular surgery, and maxillofacial surgery.

Vision: Expanding into Global Markets

Regen Allograft aims to become a global leader in regenerative medicine. By expanding its product portfolio and transferring technical expertise to international markets, the company is working to broaden its impact worldwide.

Regen Allograft Products: Advanced Solutions for Medical Treatments

The company manufactures a wide range of allograft products for various surgical applications, including:

• Demineralized Bone Matrix (DBM) Putty
• Allograft Tendons and Meniscus
• Collagen Membranes (Pericardium Membrane, Fascia Lata Membrane, Acellular Dermis)
• Heart Valves
• Bone Graft Substitutes and Fillers (Powder, Crushed, and Chips)
• Bone Blocks (Matchstick, Wedge Bone, and Shaft Bone)

Commitment to Quality and International Standards

All Regen Allograft products comply with the American Association of Tissue Banks (AATB) standards and are manufactured under the supervision of the Food and Drug Administration (FDA). This commitment ensures the highest levels of safety and effectiveness.

Listen to Our Exclusive Podcast

If you’re looking for inspiration from a success story in regenerative medicine, we invite you to tune into our podcast. Hear firsthand from the founders and experts about the challenges and innovations that have shaped their journey.

🔗 Listen Now: Visit our media section on the website or follow the link below to access the podcast directly.

 Apple Podcasts

Castbox Podcast

Share Your Comments

By listening to this podcast, you’ll gain insight into our journey and see how knowledge and dedication can bring transformation to the world of medicine. We’d love to hear your thoughts on Regen Allograft!